Cointime

Genome Canada

investment firm

About

Genome Canada invests in genomic science and technology and its translation into applications across multiple sectors.

Highlights

Investments
3
Lead Investments
1
Employee Profiles
1

Details

Industries
Financial Services
Founded date
Jan 1, 2000
Operating Status
Active

Investments

Number of Investments
Number of Lead Investments
3
1
Genome Canada has made 3 investments. Their most recent investment was on Nov 12, 2020, when Rosetta Therapeutics raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 12, 2020 Rosetta Therapeutics
Grant — Biotechnology —
Dec 5, 2016 ViewsIQ
Seed $500K Health Care Yes
Oct 20, 2014 Vasomune
Seed $1.50M Biotechnology —

Employee Profiles

Number of Employee Profiles
1
Genome Canada has 1 current employee profiles, including Executive Daryl Waggott
Daryl Waggott
Executive
Cointime
Содержание
компания